Kortrijksesteenweg 1112
box 102 Sint-Denijs-Westrem
Ghent 9051
Belgium
32 9 298 28 28
https://www.sequanamedical.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 62
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Ian Crosbie | CEO & Executive Director | 440.57k | N/A | N/A |
Ms. Kirsten Van Bockstaele | Chief Financial Officer | 355.98k | N/A | 1975 |
Ms. Lies Vanneste | Director of Investor Relations | N/A | N/A | N/A |
Mr. Martijn Blom | Chief Commercial Officer | N/A | N/A | 1974 |
Dr. Oliver Godje M.D., Ph.D. | Chief Medical Officer | N/A | N/A | 1965 |
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
Sequana Medical NV’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.